Making the Case for Metabolic Surgery in Patients With Obesity and T2DM.

Slides:



Advertisements
Similar presentations
Dr. Monica Nannipieri Dipartimento di Medicina Clinica e Sperimentale Università di Pisa.
Advertisements

Canadian Diabetes Association Clinical Practice Guidelines Weight Management in Diabetes Chapter 17 Sean Wharton, Arya M. Sharma, David C.W. Lau.
Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcome Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic.
Clinical Approaches to address the Obesity epidemic Ken Fujioka, M.D. Director of Nutrition and Metabolic Research Director of The Center for Weight Management.
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
Obesity Surgery : Is it only for losing weight ? Joint Hospital Surgical Grand Round Simon Chu Prince of Wales Hospital.
Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.
Metabolic Effects of Bariatric Surgery
Berkshire Weight Loss Surgery Royal Berkshire Hospital, Reading James Ramus, Consultant UGI & Bariatric Suregon.
Bariatric surgery is the surgery to cut off excessive fat from the body.
Bariatric Surgery for T2DM The STAMPEDE Trial. A.R. BMI 36.5 T2DM diagnosed age 24 On Metformin, glyburide  insulin Parents with T2DM, father on dialysis.
Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., John P. Kirwan, Ph.D., Kathy Wolski, M.P.H., Stacy A. Brethauer, M.D., Sankar D. Navaneethan, M.D.,
Hippocrates Prize Prof A. Kokkinos (Greece).
Bariatric Surgery Mhairri Duxbury
Osborne K.B., Davies S.J., Coppini D.V.
The Fight Against Obesity as a Disease: Tackling the Core of the Condition.
The role of metabolic surgery in the management of obesity and t2dm
Bariatric Surgery Mhairri Duxbury
The "Metabolically Healthy Obese"
Does One Size Fit All in Obesity Management?
What Comes Second?.
Achieving and Maintaining Weight Loss in Obesity: Clinical Evidence for Novel Approaches.
Patient Outcomes in Bariatric Surgery: Bridging the Divide to Postoperative Success.
Insulin Intensification Strategies in Later-Stage Type 2 Diabetes Mellitus.
Can Primary Care Physicians Take the Lead in Combating Obesity?
Novel Developments & Latest Clinical Results With Long-Acting GLP-1 Receptor Agonists.
What Do Primary Care Physicians Need to Know About Insulin/GLP-1 RA Fixed-Ratio Combinations?
Successful Obesity Management and Counseling:
Early Type 2 Diabetes Mellitus: A Cardiovascular Disease
Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.
Looking Beyond Glucose Control: Multifactorial Management of Type 2 Diabetes.
October 20, 2011 Margaux Añel-Tiangco, MD
Metabolically Healthy Patients With Obesity
Insights into Insulin Treatment Challenges: Real-World Evidence and Clinical Trial Data.
Statin Class in Session
Diabetes Increases Risk of CVD
A New Chapter for CV Risk Management in Diabetes - Challenges & Opportunities.
Statin Class in Session
Current Wellness and Health Maintenance:
Estimated Number of Cancer Cases (in Thousands) Attributable to Excess Body Mass
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Aspirin in Cardioprevention:
Panelists. Secondary Prevention in Patients With ACS and Diabetes: How Can We Optimize Therapy?
Novel Approaches to T1D Management
Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.
Practical Challenges in Obesity: Is It Possible to Maintain Weight Loss?
T2DM, CV Risk, and Modulating Risk With Glucose-Lowering Strategies
Younger Patients With Type 1 Diabetes: Can We Optimize Their Insulin Therapy?
CV Risk Reduction with Diabetes Drugs -- Should Cardiologists or Diabetologists Take the Lead?
Section overview: Cardiometabolic risk reduction
Pharmacotherapy for Diabetic Coronary Disease:
Glucose Management and Statin Therapy
LDL Cholesterol.
Obesity and Weight Loss: How Can Cross-Functional Collaboration and Integrated Care Work in Practice?
The Fight Against Obesity as a Disease: Tackling the Core of the Condition.
Program Goals Background: Anticoagulation in Patients With VTE.
Treating Obesity as a Disease: What Are the Underlying Causes?
Tackling CV Risk in Type 2 Diabetes -- Gaps Between Guidelines and Clinical Practice?
REF222 Danvers Diabetes Referral (CMS)
New Lipid-Lowering Guidelines
Obesity Management.
Anna Cowell James O’Connell Aintree Weight Management Team
Glucose Management and Statin Therapy
Type 1 Diabetes: Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors.
Statin Selection in Patients With Pre-Diabetes: Case Considerations
Managing Obesity: Scaling the Pyramid to Success
Risk Stratification of Patients With Type 2 Diabetes: An Interpretation of the Latest Treatment Guidelines.
RAASi Enabling in the Modern Era
The Elevated Role of GLP-1 RAs in Diabetes Management: Which Patients Should We Aim For?
Embracing Obesity in Collaboration -- Why, When, and How to Intervene
Presentation transcript:

Making the Case for Metabolic Surgery in Patients With Obesity and T2DM

Introduction/Overview

Obesity and T2DM: Key Correlations

Improvements in Metabolic Parameters Pre- and Post-Roux-en-Y Surgery

Post-Hoc Analysis Look AHEAD: The Importance of ≥ 10% Weight Loss

Weight Loss Is Difficult, Weight Loss Maintenance Even More So

Overall Strategy for the Treatment of Obesity[a,b]*

Obesity: Imbalance of Energy Regulation

SCALE: Change in Body Weight (%), Liraglutide vs Placebo

Roux-en-Y Gastric Bypass Induces System-Wide Physiological Changes[a,b]

Mechanisms of Bariatric Surgery[a-c]

Factors Associated With Long-Term Weight Loss Maintenance

"The Biggest Loser" and the Persistence of Metabolic Adaptation

Early Treatment Response and Stopping Rules

Characteristics of More and Less Successful Weight Loss Losers After Bariatric Surgery

Bariatric (Metabolic) Surgery Modalities

Bariatric Surgery Modalities: BPD

Diabetes Surgery Summit-II Recommendations

Despite Advances in Treatment, a Significant Proportion of Patients With T2DM Have Not Reached Target HbA1c Levels

Bariatric Surgery vs Intensive Medical Therapy for T2DM: STAMPEDE Trial

Clinical Trial Results of HbA1c Levels After Roux-en-Y Surgery vs Medical Treatment

Impact of Bariatric Surgery on Life Expectancy in Persons With T2DM and Severe Obesity

Surgery Leads to Lower Costs and Greater Health Gains vs Optimal Medical Management

Prevention of T2DM With Bariatric Surgery vs Control: SOS Study

AACE/TOS/ASMBS Guidelines: Criteria for Bariatric Surgery Recommendation

Meta-Analysis of Bariatric Surgery Risk

Anemia and Nutritional Deficiencies Associated With Bariatric Surgery

Summary and Conclusions

Abbreviations

Abbreviations (cont)